Bonny Parkinson : Citation Profile


Are you Bonny Parkinson?

Macquarie University

2

H index

1

i10 index

27

Citations

RESEARCH PRODUCTION:

14

Articles

2

Papers

RESEARCH ACTIVITY:

   11 years (2011 - 2022). See details.
   Cites by year: 2
   Journals where Bonny Parkinson has often published
   Relations with other researchers
   Recent citing documents: 0.    Total self citations: 1 (3.57 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/ppa1146
   Updated: 2024-07-05    RAS profile: 2022-09-01    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Gu, Yuanyuan (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Bonny Parkinson.

Is cited by:

Lancsar, Emily (3)

Petrie, Dennis (2)

van Exel, Job (1)

Haywood, Philip (1)

Brazier, John (1)

Gyrd-Hansen, Dorte (1)

EPSTEIN, DAVID (1)

Gu, Yuanyuan (1)

Chen, Gang (1)

Vass, Caroline (1)

Cites to:

Gray, Alastair (3)

Mortimer, Duncan (3)

Froud, Robert (3)

Hall, Jane (3)

Imbens, Guido (3)

Athey, Susan (3)

Viney, Rosalie (2)

Brazier, John (2)

Lancsar, Emily (2)

Jones, Andrew (2)

Sermet, Catherine (2)

Main data


Where Bonny Parkinson has published?


Journals with more than one article published# docs
PharmacoEconomics5
Applied Health Economics and Health Policy4
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / CHERE, University of Technology, Sydney2

Recent works citing Bonny Parkinson (2024 and 2023)


YearTitle of citing document

Works by Bonny Parkinson:


YearTitleTypeCited
2011Considering consumer choice in the economic evaluation of mandatory health programmes: A review In: Health Policy.
[Full Text][Citation analysis]
article1
2012Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04 In: Working Papers.
[Citation analysis]
paper0
2013Pharmaceutical policy in Australia. CHERE Working Paper 2013/01 In: Working Papers.
[Full Text][Citation analysis]
paper0
2011Integrating Health Economics Into the Product Development Cycle In: Medical Decision Making.
[Full Text][Citation analysis]
article5
2013Measuring the Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article2
2018The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2019Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2019Correction to: Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2014Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2022The cost-effectiveness of unilateral cochlear implants in UK adults In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review In: PharmacoEconomics.
[Full Text][Citation analysis]
article15
2016Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2016Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’ In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2019Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2022Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2022An examination of machine learning to map non?preference based patient reported outcome measures to health state utility values In: Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated June, 27 2024. Contact: CitEc Team